Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
1 February 2016 |
Main ID: |
NCT02660697 |
Date of registration:
|
18/01/2016 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
3D Radiographic Evaluation of a Novel Implant Site Development Technique
|
Scientific title:
|
3D Radiographic Evaluation of Post-extraction Healing Following Treatment With a Novel Implant Site Development Technique |
Date of first enrolment:
|
December 2007 |
Target sample size:
|
43 |
Recruitment status: |
Completed |
URL:
|
https://clinicaltrials.gov/show/NCT02660697 |
Study type:
|
Interventional |
Study design:
|
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
|
Phase:
|
Phase 4
|
|
Countries of recruitment
|
Hungary
| | | | | | | |
Contacts
|
Name:
|
Balint Molnar, DMD, PhD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Semmelweis University Department of Periodontology |
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
Presence of at least 1 single rooted tooth scheduled for extraction with EDS Class 3-4
type buccal bony dehiscence
Exclusion Criteria:
Exclusion criteria int he test group included uncontrolled inflammation at the surgical
site, full mouth plaque or bleeding scores more than 20%, diabetes, pregnancy, known
metabolic bone diseases, smoking more than 10 cigarettes a day, history of any relevant
systemic diseases, radiotherapy chronic use of bisphosphonates or systemic steroids.
Age minimum:
18 Years
Age maximum:
80 Years
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
Tooth Extraction Status Nos
|
Edentulous Alveolar Ridge
|
Intervention(s)
|
Procedure: Extraction site development
|
Primary Outcome(s)
|
Orovestibular socket dimension
[Time Frame: From baseline to 6-9 months postoperatively]
|
Secondary Outcome(s)
|
Vertical socket dimension
[Time Frame: From baseline to 6-9 months postoperatively]
|
Socket area
[Time Frame: From baseline to 6-9 months postoperatively]
|
Minimal orovestibular socket dimension feasible for implant placement
[Time Frame: From baseline to 6-9 months postoperatively]
|
Secondary ID(s)
|
XSD-Semmelweis-Perio
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|